CAR T: A New Cure for Cancer, Autoimmune and Inherited Disease

From Killer T Cells to CAR T Cells

Clinical Success for B Cell Cancers

Improving Lack of Persistence and Efficacy

Improving Limited Cytotoxicity (for Solid Tumors)

Improving Limited Proliferation

Improving Control and Safety

Improving Limited Targeting Specificity

Improving T Cell Exhaustion

Improving Manufacture: FasT CAR T cell and Off-the-Shelf CAR T Therapy